Antibodies for the Detection of Monomethyl Auristatin E (MMAE)

Sensitive assays for detection of monomethyl auristatin E (MMAE) and for antibody drug conjugates (ADC) incorporating this toxin. Antibodies also bind to the related toxins MMAD and MMAF.

  • Recombinant antibodies specific to MMAE. Antibodies also bind with similar sensitivity to MMAD. MMAF is also recognized, but with lower sensitivity
  • Sequence-defined, well characterized reagents with secure supply
  • Stringent quality control for batch-to-batch consistency
  • Nonanimal-derived antibodies, reducing the use of animals in science

Table 1. Antibodies Specific for MMAE

Specificity
Binding Type

Catalog Number

Clone

Format

Affinity* KD, nM

Assay Recommendation

Product Details

MMAE (free and conjugated)

TZA056

AbD50347ad

Fab-F-Spy2-H1

3

PK bridging ELISA (capture)

Order TZA056

TZA057

AbD50348ad

Fab-F-Spy2-H1

5

PK bridging ELISA (detection with free choice of SpyCatcher label)

Order TZA057

TZA57P

AbD50348pap

Fab2-FH-X22-HRP2

5

PK bridging ELISA (detection with HRP)

Order TZA057P

* Affinity measured in the monovalent Fab format
1 Fab-F-Spy2-H = Monovalent Fab antibody with (F) DYKDDDDK, (Spy2) SpyTag version 2, and (H) His-6-tags
Fab2-FH-X22-HRP= Bivalent Fab antibody with (F) DYKDDDDK, (H) His-6-tags and Fab-SpyTag coupled to HRP conjugated BiCatcher


Human Anti-MMAE Antibody (TZA056) inhibition ELISA against MMAE, MMAF, MMAD (Data for each cytotoxic payload were obtained from separate experiments and combined in one graph).

Human Anti-MMAE Antibody (TZA056) inhibition ELISA against MMAE, MMAF, MMAD (Data for each cytotoxic payload were obtained from separate experiments and combined in one graph).

Anti-MMAE Antibodies

The monomethyl auristatin E (MMAE) toxin is a very potent antimitotic agent used as a payload for developing antibody-drug conjugates (ADC) blocking cell division.

The anti-MMAE antibodies bind MMAE in both its free and conjugated form. They are also reactive to the closely related toxins MMAD and MMAF.

They are ideal for the development of pharmacokinetic (PK) bridging ELISAs to measure antibody drugs conjugated to those toxins.


ELISA Protocols to Get You Started

 

 

Fig. 1. MMAE conjugated antibody Brentuximab vedotin PK bridging ELISA using antibodies TZA056 and TZA057P.

Fig. 1. MMAE conjugated antibody Brentuximab vedotin PK bridging ELISA using antibodies TZA056 and TZA057P.


Related Product



Resources